『徳島大学 教育・研究者情報データベース (EDB)』---[学外] /
ID: Pass:

登録内容 (EID=296598)

EID=296598EID:296598, Map:0, LastModified:2017年12月4日(月) 14:03:07, Operator:[[ADMIN]], Avail:TRUE, Censor:承認済, Owner:[永廣 信治], Read:継承, Write:継承, Delete:継承.
種別 (必須): 学術論文 (審査論文) [継承]
言語 (必須): 英語 [継承]
招待 (推奨):
審査 (推奨):
カテゴリ (推奨):
共著種別 (推奨):
学究種別 (推奨):
組織 (推奨):
著者 (必須): 1.影治 照喜
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
2.永廣 信治
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
3.溝渕 佳史
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
4.松﨑 和仁
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
5. (英) Nagasawa Y (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
6. (英) Kumada H (日) (読)
役割 (任意):
貢献度 (任意):
学籍番号 (推奨):
[継承]
題名 (必須): (英) Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment  (日)    [継承]
副題 (任意):
要約 (任意): (英) The purpose of this study was to evaluate the clinical outcome of boron neutron capture therapy (BNCT) and conventional treatment in patients with newly diagnosed glioblastoma. Since 1998 we treated 23 newly-diagosed GBM patients with BNCT without any additional chemotherapy. Their median survival time was 19.5 months; the 2-, 3-, and 5-year survival rates were 31.8%, 22.7%, and 9.1%, respectively. The clinical results of BNCT in patients with GBM are similar to those of recent conventional treatments based on radiotherapy with concomitant and adjuvant temozolomide.  (日)    [継承]
キーワード (推奨):
発行所 (推奨):
誌名 (必須): The Journal of Medical Investigation : JMI ([徳島大学.医学部])
(pISSN: 1343-1420, eISSN: 1349-6867)

ISSN (任意): 1349-6867
ISSN: 1343-1420 (pISSN: 1343-1420, eISSN: 1349-6867)
Title: The journal of medical investigation : JMI
Title(ISO): J Med Invest
Supplier: 徳島大学
Publisher: University of Tokushima
 (NLM Catalog  (Webcat Plus  (医中誌Web  (J-STAGE  (Scopus  (CrossRef (Scopus information is found. [need login])
[継承]
[継承]
(必須): 61 [継承]
(必須): 3-4 [継承]
(必須): 254 263 [継承]
都市 (任意):
年月日 (必須): 西暦 2014年 0月 初日 (平成 26年 0月 初日) [継承]
URL (任意):
DOI (任意): 10.2152/jmi.61.254    (→Scopusで検索) [継承]
PMID (任意): 25264042    (→Scopusで検索) [継承]
CRID (任意):
WOS (任意):
Scopus (任意): 2-s2.0-84907567821 [継承]
機関リポジトリ : 109564 [継承]
評価値 (任意):
被引用数 (任意):
指導教員 (推奨):
備考 (任意): 1.(英) Article.PublicationTypeList.PublicationType: Journal Article  (日)    [継承]

標準的な表示

和文冊子 ● Teruyoshi Kageji, Shinji Nagahiro, Yoshifumi Mizobuchi, Kazuhito Matsuzaki, Y Nagasawa and H Kumada : Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment, The Journal of Medical Investigation : JMI, 61, 3-4, 254-263, 2014.
欧文冊子 ● Teruyoshi Kageji, Shinji Nagahiro, Yoshifumi Mizobuchi, Kazuhito Matsuzaki, Y Nagasawa and H Kumada : Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment, The Journal of Medical Investigation : JMI, 61, 3-4, 254-263, 2014.

関連情報

Number of session users = 1, LA = 1.76, Max(EID) = 437879, Max(EOID) = 1161148.